Investment
Features
FeesSafety
Academy
More
Pluang+

Searles Valley Minerals to sell assets to 5E Advanced Materials in court-approved deal

Company Fundamentals
15 Sep 2026
PRNewsWire
View Source
Bullish
Searles Valley Minerals to sell assets to 5E Advanced Materials in court-approved deal

Searles Valley Minerals has agreed to sell most of its operating assets to 5E Advanced Materials through a court-supervised Section 363 sale as part of its bankruptcy process. The deal includes production plants, brine resources, railway, and water facilities in California, with 5E paying cash, stock, and a senior note totaling over $9.5 million. The transaction aims to ensure long-term investment and continued operations, preserving jobs and community services, with closing expected in October 2026 pending court and regulatory approvals. Searles Valley will continue normal operations during the transition.

Searles Valley Minerals is the subject of this asset sale news. For readers following Basic Materials, here is Pluang's market snapshot as of Sep 15, 2026 21:43 WIB: Among 32 priced US stocks, 10 rose and 22 fell. Notable movers include Dow Inc at USD 29.39 with a 1-day change of +1.68%, Harmony Gold Mining Co. at USD 19.28 down 1.78%, and Agnico Eagle Mines Ltd at USD 194.40 down 1.59%.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App